Instrumento Inactivo

Otros idiomas Gridiron Bionutrients Inc Other OTC

Acciones

US62847K1025

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Innovation1 Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023	17/01
Innovation1 Biotech Inc. announced that it has received $0.15 million in funding	06/12
Innovation1 Biotech Inc. announced that it has received $0.02 million in funding	01/11
Innovation1 Biotech : New Financial Obligation - Form 8-K	16/10/23
Innovation1 Biotech Inc. announced that it has received $0.02 million in funding	11/10/23
Innovation1 Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023	13/09/23
Innovation1 Biotech Inc. announced that it has received $0.066891 million in funding	01/09/23
Innovation1 Biotech Inc. Announces Resignation of Patrick Morris as Chairman of the Board	11/08/23
Innovation1 Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2023	30/05/23
Innovation1 Biotech Inc. Announces Resignation of Jeffrey Kraws as a Director	24/04/23
Innovation1 Biotech : Material Agreement - Form 8-K	24/04/23
INNOVATION1 BIOTECH INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	24/04/23
Innovation1 Biotech Inc. announced that it expects to receive $0.28 million in funding from Cavalry Fund I Management, LLC, Lincoln Park Capital, LLC, L1 Capital Pty. Limited	13/04/23
INNOVATION1 BIOTECH INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	17/01/23
Innovation1 Biotech Inc. Reports Earnings Results for the First Quarter Ended November 30, 2022	17/01/23
Innovation1 Biotech Inc. announced that it has received $0.3 million in funding from Cavalry Fund I Management, LLC, L1 Capital Pty. Limited, Lincoln Park Capital, LLC	27/12/22
Innovation1 Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2022	15/12/22
INNOVATION1 BIOTECH INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	15/12/22
Innovation1 Biotech Inc. Auditor Raises 'Going Concern' Doubt	15/12/22
INNOVATION1 BIOTECH INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	12/12/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Gridiron Bionutrients Inc Other OTC

Acciones

US62847K1025

Otros idiomas

Filtros